All Services
Scientific Due Diligence
Rapid PhD-level scientific assessment for biotech investment decisions — technology feasibility, IP strength, and key risk factors in days, not weeks.
From $3,500|48–72 hour turnaround
Deliverables
What You Get
- Technology feasibility assessment (does the science hold up?)
- IP portfolio strength evaluation
- Competitive positioning in the patent literature
- Key risk identification (scientific, regulatory, IP)
- Publication and citation analysis
- Team capability assessment
- Executive summary + detailed technical report
Ideal For
Who This Is For
- Venture capital firms evaluating biotech investments
- Family offices and angel investors in life sciences
- Corporate development teams assessing acquisition targets
- Strategic partners evaluating licensing deals
Investment
Transparent Pricing
Rapid Assessment
48–72 hours, 5–10 page report
$3,500
Standard DD
1–2 weeks, 20–30 page report
$7,500
Comprehensive DD
2–4 weeks, 40+ page report
$15,000+
Turnaround: 48 hours to 4 weeks depending on scope
Ready to get started?
Request a proposal with your specific requirements and receive a detailed scope and timeline within 24 hours.
Request a Proposal